Jeffrey M. Johnston

4.7k total citations · 1 hit paper
87 papers, 3.5k citations indexed

About

Jeffrey M. Johnston is a scholar working on Gastroenterology, Surgery and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Jeffrey M. Johnston has authored 87 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Gastroenterology, 38 papers in Surgery and 9 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Jeffrey M. Johnston's work include Gastrointestinal motility and disorders (51 papers), Congenital gastrointestinal and neural anomalies (23 papers) and Gastroesophageal reflux and treatments (18 papers). Jeffrey M. Johnston is often cited by papers focused on Gastrointestinal motility and disorders (51 papers), Congenital gastrointestinal and neural anomalies (23 papers) and Gastroesophageal reflux and treatments (18 papers). Jeffrey M. Johnston collaborates with scholars based in United States, United Kingdom and Japan. Jeffrey M. Johnston's co-authors include Mark G. Currie, Caroline B. Kurtz, James E. MacDougall, Bernard J. Lavins, Anthony Lembo, Steven J. Shiff, Donald A. Fitch, Harvey Schneier, Xinwei D. Jia and James Shao and has published in prestigious journals such as New England Journal of Medicine, JAMA and The Journal of Immunology.

In The Last Decade

Jeffrey M. Johnston

86 papers receiving 3.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Linaclotide for Irritable Bowel Syndrome With Constipation: A 26-Week, Randomized, Double-blind, Placebo-Controlled Trial to Evaluate Efficacy and Safety

2012 340 citations William D. Chey, Anthony Lembo et al. The American Journal of Gastroenterology profile →

Peers

Countries citing papers authored by Jeffrey M. Johnston

Since Specialization

Citations

This map shows the geographic impact of Jeffrey M. Johnston's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey M. Johnston with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey M. Johnston more than expected).

Fields of papers citing papers by Jeffrey M. Johnston

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeffrey M. Johnston. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey M. Johnston. The network helps show where Jeffrey M. Johnston may publish in the future.

Co-authorship network of co-authors of Jeffrey M. Johnston

This figure shows the co-authorship network connecting the top 25 collaborators of Jeffrey M. Johnston. A scholar is included among the top collaborators of Jeffrey M. Johnston based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeffrey M. Johnston. Jeffrey M. Johnston is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Linaclotide in irritable bowel syndrome with constipation: A Phase 3 randomized trial in China and other regions 2018 ·Journal of Gastroenterology and Hepatology ·Yunsheng Yang, (unknown), Jing‐Yuan Fang, Xiaozhong Guo, Ning Dai, Xizhong Shen, Youlin Yang, Jing Sun, Bal Raj Bhandari, David S. Reasner, (unknown), Mark G. Currie, Jeffrey M. Johnston, Peter YF. Zeng, (unknown), (unknown), Sam Lim	39
2	Linaclotide in Chronic Idiopathic Constipation Patients with Moderate to Severe Abdominal Bloating: A Randomized, Controlled Trial 2015 ·PLoS ONE ·Brian E. Lacy, Ron Schey, Steven J. Shiff, Bernard J. Lavins, Susan M. Fox, Xinwei D. Jia, Rick E. Blakesley, (unknown), (unknown), Mark G. Currie, Caroline B. Kurtz, Jeffrey M. Johnston, Anthony Lembo	56
3	Impact of linaclotide on work productivity and daily activity impairment among adults with irritable bowel syndrome with constipation: results from a 26-week phase 3 trial 2014 ·Value in Health ·(unknown), Stavros Tourkodimitris, (unknown), Jeffrey M. Johnston, Robyn T. Carson	1
4	Comparison of adequate relief with symptom, global, and responder endpoints in linaclotide phase 3 trials in IBS‐C 2014 ·United European Gastroenterology Journal ·Michael Camilleri, Anthony Lembo, Bernard J. Lavins, James E. MacDougall, Robyn T. Carson, Valerie Williams, Lauren Nelson, Steven J. Shiff, Mark G. Currie, Caroline B. Kurtz, Jeffrey M. Johnston	11
5	Measuring the Symptoms of Pediatric Constipation and Irritable Bowel Syndrome with Constipation: Expert Commentary and Literature Review 2014 ·Patient ·Robert Arbuckle, Robyn T. Carson, Linda Abetz‐Webb, Jeffrey S. Hyams, (unknown), Barbara Edelman Lewis, Elizabeth Gargon, Caroline B. Kurtz, Steven J. Shiff, Jeffrey M. Johnston	5
6	Linaclotide Inhibits Colonic Nociceptors and Relieves Abdominal Pain via Guanylate Cyclase-C and Extracellular Cyclic Guanosine 3′,5′-Monophosphate 2013 ·Gastroenterology ·Joel Castro, Andrea M. Harrington, Patrick A. Hughes, Christopher M. Martin, Pei Ge, Courtney Shea, Hong Jin, Sarah Jacobson, Gerhard Hannig, Elizabeth A. Mann, Mitchell B. Cohen, James E. MacDougall, Bernard J. Lavins, Caroline B. Kurtz, Inmaculada Silos‐Santiago, Jeffrey M. Johnston, Mark G. Currie, L. Ashley Blackshaw, Stuart M. Brierley	228
7	Randomised clinical trials: linaclotide phase 3 studies in IBS ‐C – a prespecified further analysis based on European Medicines Agency‐specified endpoints 2012 ·Alimentary Pharmacology & Therapeutics ·Eamonn M.M. Quigley, Jan Tack, William D. Chey, (unknown), J Fortea, M. Falqués, (unknown), Steven J. Shiff, Mark G. Currie, Jeffrey M. Johnston	92
8	A 12-Week, Randomized, Controlled Trial With a 4-Week Randomized Withdrawal Period to Evaluate the Efficacy and Safety of Linaclotide in Irritable Bowel Syndrome With Constipation 2012 ·The American Journal of Gastroenterology ·Satish S.C. Rao, Anthony Lembo, Steven J. Shiff, Bernard J. Lavins, Mark G. Currie, Xinwei D. Jia, Kelvin Shi, James E. MacDougall, James Shao, Paul Eng, Susan M. Fox, Harvey Schneier, Caroline B. Kurtz, Jeffrey M. Johnston	293
9	Linaclotide for Irritable Bowel Syndrome With Constipation: A 26-Week, Randomized, Double-blind, Placebo-Controlled Trial to Evaluate Efficacy and Safety breakdown → 2012 ·The American Journal of Gastroenterology ·William D. Chey, Anthony Lembo, Bernard J. Lavins, Steven J. Shiff, Caroline B. Kurtz, Mark G. Currie, James E. MacDougall, Xinwei D. Jia, James Shao, Donald A. Fitch, Mollie Baird, Harvey Schneier, Jeffrey M. Johnston	340
10	Sa1098 Mediation Analysis Supports a Direct Effect of Linaclotide on Relief of Abdominal Pain Independent of Constipation Improvement 2012 ·Gastroenterology ·James E. MacDougall, David P. MacKinnon, Bernard J. Lavins, Anthony Lembo, Steven J. Shiff, Harvey Schneier, (unknown), Mark G. Currie, Jeffrey M. Johnston	4
11	A review of the clinical efficacy of linaclotide in irritable bowel syndrome with constipation 2012 ·Current Medical Research and Opinion ·Jeffrey M. Johnston, Steven J. Shiff, Eamonn M.M. Quigley	11
12	Two Randomized Trials of Linaclotide for Chronic Constipation 2011 ·New England Journal of Medicine ·Anthony Lembo, Harvey Schneier, Steven J. Shiff, Caroline B. Kurtz, James E. MacDougall, Xinwei D. Jia, James Shao, Bernard J. Lavins, Mark G. Currie, Donald A. Fitch, Brenda I. Jeglinski, Paul Eng, Susan M. Fox, Jeffrey M. Johnston	270
13	Linaclotide Improves Abdominal Pain and Bowel Habits in a Phase IIb Study of Patients With Irritable Bowel Syndrome With Constipation 2010 ·Gastroenterology ·Jeffrey M. Johnston, Caroline B. Kurtz, James E. MacDougall, Bernard J. Lavins, Mark G. Currie, Donald A. Fitch, (unknown), Mollie Baird, Anthony Lembo	177
14	Efficacy of Linaclotide for Patients With Chronic Constipation 2010 ·Gastroenterology ·Anthony Lembo, Caroline B. Kurtz, James E. MacDougall, Bernard J. Lavins, Mark G. Currie, Donald A. Fitch, Brenda I. Jeglinski, Jeffrey M. Johnston	170
15	Pilot Study on the Effect of Linaclotide in Patients With Chronic Constipation 2008 ·The American Journal of Gastroenterology ·Jeffrey M. Johnston, Caroline B. Kurtz, Douglas A. Drossman, Anthony Lembo, Brenda I. Jeglinski, James E. MacDougall, (unknown), Mark G. Currie	93
16	A numerical evaluation of electromagnetic methods in geothermal exploration 1996 ·Geophysics ·Louise Pellerin, Jeffrey M. Johnston, Gerald W. Hohmann	118
17	CAMPATH-1H IN RHEUMATOID ARTHRITIS—AN INTRAVENOUS DOSE-RANGING STUDY 1996 ·Lara D. Veeken ·John D. Isaacs, Vasant K. Manna, N T Rapson, Ken J. Bulpitt, B. L. Hazleman, Eric L. Matteson, E. William St. Clair, Thomas J. Schnitzer, Jeffrey M. Johnston	86
18	Treatment of active refractory rheumatoid arthritis with humanized monoclonal antibody campath‐1h administered by daily subcutaneous injection 1995 ·Arthritis & Rheumatism ·Eric L. Matteson, David E. Yocum, E. William St. Clair, (unknown), (unknown), (unknown), (unknown), (unknown), Jeffrey M. Johnston	58
19	Campath‐1h, a humanized monoclonal antibody, in refractory rheumatoid arthritis 1995 ·Arthritis & Rheumatism ·Michael E. Weinblatt, Peter J. Maddison, Ken J. Bulpitt, B L Hazleman, Murray B. Urowitz, R D Sturrock, Jonathan S. Coblyn, Agnes L. Maier, William Spreen, Vasant K. Manna, Jeffrey M. Johnston	93
20	The Use of Interferon-α in Virus Infections 1991 ·Drugs ·N. B. Finter, Stephanie Chapman, Pauline M. Dowd, Jeffrey M. Johnston, Vasant K. Manna, (unknown), Nick Sheron, (unknown), (unknown), (unknown)	48

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact